U.S. Software Stock News

Long term investing works well, but it doesn't always work for each individual stock. It hits us in the gut when we see...

Abbott Laboratories ( NYSE:ABT ) announced strong profits, but the stock was stagnant. Our analysis suggests that...

Whilst it may not be a huge deal, we thought it was good to see that the Myers Industries, Inc. ( NYSE:MYE...

Even though Xos, Inc. ( NASDAQ:XOS ) has fallen by 13% over the past week , insiders who sold US$124k worth of stock...

Key Insights Significant control over Aquestive Therapeutics by retail investors implies that the general public has...

GoPro, Inc. ( NASDAQ:GPRO ) shares have retraced a considerable 25% in the last month, reversing a fair amount of their...

With the business potentially at an important milestone, we thought we'd take a closer look at BioRestorative...

Primech Holdings Ltd. ( NASDAQ:PMEC ) shareholders won't be pleased to see that the share price has had a very rough...

Madrigal Pharmaceuticals (MDGL) remains in the red, with losses widening at a 15.3% annual rate over the last five years and net profit margins not improving in that period. Looking ahead, analysts forecast annual revenue growth of 34.8% and earnings growth of 67.2% per year, setting the company on a path to profitability within three years. This represents a much faster trajectory than the US market’s projected 10.5% revenue growth. With shares trading below an estimated fair value and the...

Ever found yourself wondering if Liquidia’s explosive growth means it’s a bargain or a bubble? Let’s break down whether there’s still value left for investors. This stock has been on a roll lately, soaring 20.6% in the past week, up 24.4% over the month, and a massive 130.7% year-to-date, topping off a 167.6% gain in the past year. Recent momentum goes beyond simple trading swings. Just last week, Liquidia announced a favorable regulatory breakthrough on its lead...

AmpliTech Group, Inc. ( NASDAQ:AMPG ) shares have retraced a considerable 28% in the last month, reversing a fair...

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Halozyme Therapeutics (HALO) posted net profit margins of 47.9%, a significant jump from last year’s 41.4%, as earnings growth for the year hit 51.7%. This figure is twice its five-year average of 20.8% per year. Looking ahead, analysts expect earnings and revenue to continue rising by around 11.6% annually. The company’s price-to-earnings ratio of 13.4x sits comfortably below both the US biotech average of 16.9x and peers at 19.6x. Investors are eyeing the combination of strong...

Insiders who acquired US$347.5k worth of Jasper Therapeutics, Inc.'s ( NASDAQ:JSPR ) stock at an average price of...

DHT Holdings, Inc. ( NYSE:DHT ) posted some decent earnings, but shareholders didn't react strongly. We think that they...

Aurinia Pharmaceuticals (AUPH) has flipped to profitability after five years of transformation, posting average annual earnings growth of 43.8%. Forward guidance points to EPS growth of 17.13% per year and revenue growth of 12.5% per year, both topping the US market average of 10.5%. Improving net profit margins and high-quality earnings continue to shape investor sentiment heading into the latest results. See our full analysis for Aurinia Pharmaceuticals. Next, we will see how these...

Key Insights Neuphoria Therapeutics' estimated fair value is US$3.35 based on 2 Stage Free Cash Flow to Equity...

Molson Coors Beverage (TAP) is forecast to turn profitable within the next three years, with projected earnings growth of 65.59% annually. Revenue, however, is expected to rise just 0.6% per year, well below the US market average of 10.5%. While the company remains unprofitable in the latest results, losses have declined at an annual rate of 17.4% over the past five years. At $43.67 per share, TAP trades at a price-to-sales multiple of 0.8x, below both peer and sector averages, and notably...

Unfortunately for some shareholders, the FG Nexus Inc. ( NASDAQ:FGNX ) share price has dived 42% in the last thirty...

The market rallied behind Materialise NV's ( NASDAQ:MTLS ) stock, leading do a rise in the share price after its recent...

To the annoyance of some shareholders, iOThree Limited ( NASDAQ:IOTR ) shares are down a considerable 27% in the last...

Ensign Group (ENSG) posted a net profit margin of 6.8%, topping last year’s 5.8%, with earnings growing 36.8% over the past year, well ahead of its five-year average of 12.7%. The company’s high-quality earnings and larger margins come as shares currently trade at $183.98, below an estimated fair value of $207.65. Looking forward, earnings are projected to grow 14.8% each year and revenue is expected to rise 10.8% annually, which is slightly faster than the broader US market’s 10.5% rate...

Wondering if Brink's is truly a bargain or if recent buzz is just noise? Let’s cut through the headlines and get straight into what matters for value-focused investors. After a sharp drop of 8.2% in the past week and a 7.8% dip over the past month, Brink's still boasts long-term gains, up 14.6% year-to-date and 107.6% over five years. Much of this recent volatility tracks broader market swings and reactions to industry-wide security developments. Investor sentiment has shifted in response to...